Individuals with the downgraded Lynch syndrome variants (MLH1, MSH2) would have been recommended to undergo Lynch syndrome-associated cancer screening (noted above) instead of screening based on their family history of cancer alone. This evidence concerns the gene MLH1 and Lynch syndrome.